{"slideshow_credits": null, "snippet": "Mylan would combine Abbott\u2019s generic drug operations in Europe, Japan, Canada, Australia and New Zealand with its existing operations and reincorporate in the Netherlands in an inversion.", "abstract": "Mylan would combine Abbott\u2019s generic drug operations in Europe, Japan, Canada, Australia and New Zealand with its existing operations and reincorporate in the Netherlands in an inversion.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/07/14/mylan-to-buy-generics-drugs-business-outside-u-s-from-abbott-for-5-3-billion/", "lead_paragraph": null, "headline": {"main": "Mylan to Buy Abbott's Generic Drug Business Outside U.S. for $5.3 Billion", "kicker": "DealBook"}, "_id": "53c3bf1f38f0d8297e22dfd4", "word_count": "513", "multimedia": [{"height": 126, "url": "images/2014/07/14/business/dealbook/dbpix-mylan/dbpix-mylan-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/07/14/business/dealbook/dbpix-mylan/dbpix-mylan-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/07/14/business/dealbook/dbpix-mylan/dbpix-mylan-articleLarge.jpg", "legacy": {"xlarge": "images/2014/07/14/business/dealbook/dbpix-mylan/dbpix-mylan-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/07/14/business/dealbook/dbpix-mylan/dbpix-mylan-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/07/14/business/dealbook/dbpix-mylan/dbpix-mylan-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-07-14T07:28:19Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "White, Miles D", "rank": "1"}, {"name": "glocations", "value": "Netherlands", "rank": "1"}, {"name": "organizations", "value": "Mylan Inc", "rank": "5"}, {"name": "organizations", "value": "Shire PLC", "rank": "6"}, {"name": "organizations", "value": "AbbVie Inc", "rank": "2"}, {"name": "organizations", "value": "Meda AB", "rank": "3"}, {"name": "organizations", "value": "Morgan Stanley", "rank": "4"}, {"name": "organizations", "value": "Abbott Laboratories", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}, {"name": "subject", "value": "Generic Brands and Products", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}